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(IEGM) -based method and echocardiography and assess whether the acute hemo-
dynamic effects achieved by modiﬁed IEGM-based method are more effective and
more accurate comparing with the traditional IEGM-based method.
Methods: A total number of 20 patients with congestive heart failure implanted with
IEGM-based functioned CRT/CRT-D were enrolled. The follow-up period for all the
patients after CRT was 1, 3 and 6 months. Modiﬁed IEGM -based method, traditional
IEGM -based method and echocardiography respectively was used to achieve the
optimized VV delays and assessed the improvement degree of acute hemodynamic
effects by the three different methods.
Results: The results showed the optimized VV delays achieved by modiﬁed IEGM-
based method have better agreement and correlation with the echocardiographic
optimization comparing with the traditional IEGM-based method. The parameter of
left ventricular ejection fraction (LVEF) by modiﬁed IEGM-based method was
independently related to more favorable outcomes than the traditional echocardiog-
raphy during the 1, 3 and 6 months follow-up period (0.310.07 vs 0.290.08,
0.370.07 vs 0.340.08, 0.450.07 vs 0.420.08 P<0.05). Moreover, the degree of
the mitral regurgitation decreased markedly by modiﬁed IEGM-based method in 6
months follow-up after CRT (2.081.78 vs 2.642.37, P<0.05). However, there was
no statistically signiﬁcance between the traditional IEGM method and modiﬁed
IEGM-based method in A Wave Velocity-time Integral (VTIAo) and the degree of the
mitral regurgitation in 1, 3 months follow-up after CRT (P>0.05).
Conclusions: (1) The optimized VV delays achieved by modiﬁed IEGM-based
method have better agreement and correlation with the echo optimization comparing
with the traditional IEGM-based method. (2) The optimized VV delays achieved by
modiﬁed IEGM-based method have better acute hemodynamic effects.
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Objectives: Obesity is an important risk factor for atrial ﬁbrillation (AF). Epicardial
adipose tissue in close anatomic proximity to cardiac structures and autonomic ﬁbers,
is a source of several inﬂammatory mediators related to the genesis of AF. This study
is aimed to investigate the relationship of thickness of left atrial epicardial adipose
tissue and atrial ﬁbrillation.
Methods: 150 consecutive hospitalized patients with AF from the January 2008 to
January 2009 underwent 16-slice spiral CT as the experimental group (48 (32%)
patients with persistent AF, 102 (68%) patients with paroxysmal AF). 131 cases of
non-AF patients in our outpatient for 16-slice spiral spiral CT as a control group. In a
short-axis view of the mid-left atrium (LA), periatrial epicardial adipose tissue was
measured at the esophagus (LA-ESO), main pulmonary artery (LA-PA), and thoracic
aorta (LA-TA). Axial plane measurement of the anteroposterior diameter, sagittal
measurement of the vertical diameter were performed as the LA diameter.
Results: Left atrial epicardial adipose tissue thickness in patients with persistent atrial
ﬁbrillation increased than that in patients with paroxysmal atrial ﬁbrillation and
without atrial ﬁbrillation (all P value less than 0.05). Epicardial adipose tissue
thickness in patients with persistent atrial ﬁbrillation increased than that in patients
with paroxysmal atrial ﬁbrillation (all P value less than 0.05). Adjusted for age, sex,
hypertension, diabetes, BMI and left atrial size, left trial epicardial adipose tissue
thickness had relationship with AF history duration and AF burden.
Conclusions: Left atrial epicardial adipose tissue thickness was independently asso-
ciated with AF duration and AF burden.
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Objectives: To summarize the experience and outcomes of radiofrequency catheter
ablation (RFCA) of electrical storm after implantation of implantable cardiovertor
deﬁbrillator (ICD-ES).
Methods: We reviewed 5 cases of ICD-ES who underwent RFCA guided by 3D
mapping systems. All the patients received endocardial mappings, while selected
patients received epicardial mappings. Both activation and substrate mappings were
obtained for hemodynamically stable and persistent VTs, while only substrate
mappings were obtained for hemodynamically unstable or impersistent VTs. Areas of
dense scars (voltage <0.5 mV) and transitional zones (TZ, voltage between 0.5 to 1.5
mV) were calculated. Ablation targets included: (1) The earliest activation sites of focal
and micro-reentrant VTs. (2) Best paced map sites. (3) Critical isthmuses. (4) Potential
conduction channels within low-voltage zones (LVZ). Endpoints included: (1) No
induction of persistent VTs by isoprenaline and programmed stimulation; (2) Elimi-
nation of abnormal potentials in LVZs; (3) Connection of nearby barriers.
Results: There were 2 patients with previous myocardial infarction, 2 patiants with
arrhythmogenic right ventricular cardiomyopathy (ARVC), and 1 patient with normal
heart structure. There induced an average of 3.43.0 VTs in each case with mean
cycle length of 389.0122.4 ms. Two cases only received endocardial voltage
mappings of targeted ventricles and endo-cardial LVZ was found in one of them
(112.0 cm2). Three cases received both endo - (32193 points) and epi-cardial
(302158 points) voltage mapping in targeted ventricles during SR and LVZs wereC156 JACC Vol 64/16/Suppl C j October 16–1detected in two of them. Epi-LVZ areas were larger than endo-LVZ areas in the two
cases (100.217.7 cm2 versus 48.041.1 cm2). No acute adverse events were
observed. None suffered from ICD shocks during an average of 24.813.7 months’
follow-up. One patient has been hospitalized for heart failure for three times post-
procedure. His present heart function is NYHA grade III, the same with pre-procedure.
Conclusions: Substrate mapping is helpful for complicated VTs due to ICD-ES.
GW25-e4375
Early clinical experience of left atrial appendix occlusion using LAmbreTM device
from a 7-case series
Li Shuang, Yawei Xu, Kai Tang, Wei Chen
Department of Cardiology, Shanghai Tenth People’s Hospital, Tongji University
Objectives: Left atrial appendix is the main origin of thromboembolus that causes
ischemic stroke in the patients with atrial ﬁbrillation (AF). Percutaneous left atrial
appendix occlusion (LAAO) is a potential method for prevention of stroke. In these
series, we performed LAAO using novel LAmbreTM device, to detect its abilities of
occlusive effectiveness, percutaneous operability and safety.
Methods: Patients with non-valvular AF that were intolerant to warfarin therapy were
recruited after performing a rigorous exclusive screening. Suitable LAmbreTM device
were selected by coronary angiography and released into LAA, prior to assessment of
residual shunt by transesophageal echocardiography (TEE). Operability of device was
evaluated by a same operator, objectively.
Results: Seven patients with non-valvular AF that received irregular warfarin therapy
were selected out, after exclusion of 1 in 8 cases as existence of mural thrombus
detected by TEE. Among all 7 inclusive cases, 6 were female and 1 was male, 6 were
permanent AF and 1 was paroxysmal AF. The average age was 677. Four had a
history of prior stroke and/or transient ischemic stroke. CHADS2 score was 2.71.25
and international normalized ratio (INR) was 1.30.72, including only 1 reached the
target (INR 2-3). Pre-procedural ejection fraction of left ventricle was 616.9 percent.
Under continuous monitoring of TEE, all cases underwent LAAO using LAmbreTM
devices. Five no, 1 slight and 1 mild residual shunts indicated all success of pro-
cedures. Average time-cost was 7016.9 minutes. There were also satisﬁed evalua-
tions of supporting, contrastive, stable and positioning abilities for the devices. These
patients underwent uneventful recovery. The time between the procedure and
discharge was 30.5 days.
Conclusions: Percutaneous left atrial appendix occlusion with LAmbreTM device was
safe and effective, however, long-term follow-up should be evaluated closely.
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Objectives: Cardiac resynchronization therapy (CRT) was an established treatment of
chronic heart failure for nearly 20 years. Myocardial ischemia is an independent
predictor of CRT no response, and high cardiovascular mortality after CRT and high
hospitalization rate. Patients with ischemic cardiomyopathy could beneﬁt from CRT,
but occurs to a lesser degree. In addition, an optimal position can signiﬁcantly improve
CRT response rate, but it is not clear that weather the same left ventricular lead
position in heart failure patients of different etiology would have the same effect.
Methods: From 2001 March to 2012 December, 187 heart failure patients treated with
CRT and ﬁnished 6 months follow-up were enrolled in this study, the patients were
from 3 medical centers. Left ventricle lead were placed through thoracic epicardium in
3 cases, the remaining 184 cases were through venous. The LV lead was implanted
preferably in the lateral or posterolateral vein. Right ventricular lead positioning at
septum were depended on ﬂuoroscopic imagine and electrocardiogram, as Lieberman
discribed. From coronary sinus to the apex, the heart was classiﬁed into basal, mid-
ventricular (MID), and apical segments along the long axis at right anterior oblique
(RAO) view of venogram. The pacemaker was programmed to maximum biven-
tricular pacing, the output voltage were reduced as far as possible to extending battery
life. Before and after the implantation of pacemaker, 12 lead ECG were recorded (25
mm/s), QRS duration in II, V1 and V6 were measured by two doctors independently.
Results: NYHA symptom class, 6-MWT, LVEDD and LVEF were signiﬁcantly
improved at 6 months in NICM group (P<0.01), NYHA symptom class, 6-MWT and
LVEF improved in ICM group at 6 months (P<0.01), while LVEDD did not
improved. The improvements in NICM were more obvious than ICM group (P<0.01).
The improvement of NYHA class and LVEF in NICM group when LV lead placed in
the middle segment is more obvious than placed in the basal segment (P<0.05-0.01).
And the improvement of NYHA class, LVEDD and LVEF is more signiﬁcant than LV
lead placement in the apical segment (P<0.01), and the absolute improvement value
of all heart function characters were more signiﬁcant compared to the LV lead placed
in basal and apical segment. In ICM group, the improvement of LVEDD when LV
lead positioning in the basal segment was more obvious than in the middle segment
(P<0.05), and all the indexes were improved more obviously than in apical segment
(P<0.05-0.01), the absolute improvement value were more signiﬁcant compared to
middle and apical segment.
Conclusions: The treatment with CRT can obtain certain curative effect for heart
failure patients of ICM, but not as good as NICM, especially if the left ventricular
remodeling cannot reverse. The best position of LV lead in NICM was basal heart,
while for ICM patients the best position is middle heart.9, 2014 j GW-ICC Abstracts/Cardiovascular Disease Clinical Research
